A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension

Compliance Study Comparing DuoTrav to TRAVATAN Plus Timolol Using the Dosing Aid

The purpose of this study is to assess patient compliance with DuoTrav versus concomitant administration of Timolol 0.5% plus TRAVATAN in patients with open-angle glaucoma or ocular hypertension.

Inclusion Criteria:

• Adult patients with open-angle glaucoma or ocular hypertension;
• Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

• Visual acuity worse than 0.60;
• Other protocol-defined exclusion criteria may apply.